# Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

> **NCT00334594** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 153 (actual)

## Conditions studied

- Malignant Mesothelioma

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Pemetrexed
- **PROCEDURE:** Therapeutic conventional surgery
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00334594
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-14
- **Primary completion:** 2014-03-26
- **Final completion:** 2018-01-23
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2019-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00334594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00334594, "Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00334594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*